Plumeria Therapeutics, Inc.
PrivateLast Round
Grant
Oct 30, 2025
Total Funding Raised
$3.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Plumeria Therapeutics, Inc. is a clinical-stage biotechnology company developing non-opioid pain treatments and companion diagnostics for chronic pain conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plumeria Therapeutics, Inc. Comparables
Compare Plumeria Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaremed AG | 79% | |
| Latigo Biotherapeutics | 79% | |
| EicOsis Human Health, Inc. | 78% |
Plumeria Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 30, 2025 | ||||
| Grant | Oct 30, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| Grant | Aug 9, 2022 | ||||
| Grant | Jan 20, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Secured $3M in grant funding.
- Oct 30, 2025
Secured $40K in grant funding.
Plumeria Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Plumeria Therapeutics, Inc.'s valuation, stock price, and market status.
Is Plumeria Therapeutics, Inc. a public or private company?
Plumeria Therapeutics, Inc. is a private company.
What is the current stock price of Plumeria Therapeutics, Inc.?
Plumeria Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Plumeria Therapeutics, Inc. worth (valuation)?
Valuation information for Plumeria Therapeutics, Inc. is not publicly available.
Can I buy Plumeria Therapeutics, Inc. stock?
Plumeria Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Plumeria Therapeutics, Inc.'s last funding round?
Funding round information for Plumeria Therapeutics, Inc. is not publicly available.
Who are the main investors in Plumeria Therapeutics, Inc.?
Investor information for Plumeria Therapeutics, Inc. is not publicly disclosed.
Will Plumeria Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Plumeria Therapeutics, Inc..
How can I track Plumeria Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Plumeria Therapeutics, Inc.'s secondary market activity and sign up for updates.